VYNE Therapeutics VYNE
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 0.58 | 28 | -16.16 | -5 | -14.59 | 30 |
| 2025Q3 | 0.34 | 32 | -20.52 | -7 | -18.01 | 36 |
| 2025Q2 | 1.65 | 39 | -13.87 | -6 | -11.38 | 45 |
| 2025Q1 | 1.58 | 44 | -17.90 | -9 | -13.96 | 56 |
| 2024Q4 | 3.35 | 52 | -20.80 | -12 | -16.80 | 67 |
| 2024Q3 | 1.88 | 64 | -17.57 | -12 | -14.93 | 76 |
| 2024Q2 | 1.97 | 75 | -11.89 | -9 | -10.55 | 87 |
| 2024Q1 | 3.07 | 83 | -7.26 | -6 | -6.60 | 92 |
| 2023Q4 | 2.33 | 89 | -12.35 | -6 | -10.58 | 98 |
| 2023Q3 | 4.04 | 12 | -45.76 | -7 | -29.77 | 19 |
| 2023Q2 | 4.10 | 17 | -46.03 | -10 | -33.40 | 25 |
| 2023Q1 | 3.08 | 26 | -19.51 | -6 | -14.79 | 35 |
| 2022Q4 | 2.70 | 31 | -27.91 | -10 | -22.69 | 41 |
| 2022Q3 | 4.02 | 40 | -21.39 | -9 | -18.53 | 47 |
| 2022Q2 | 7.00 | 48 | -16.29 | -8 | -14.18 | 55 |
| 2022Q1 | 11.70 | 56 | 8.95 | 5 | 7.11 | 64 |
| 2021Q4 | 18.36 | 49 | -21.52 | -12 | -15.60 | 67 |
| 2021Q3 | 25.02 | 59 | -31.82 | -21 | -19.77 | 81 |
| 2021Q2 | 63.18 | 75 | -23.75 | -20 | -14.07 | 134 |
| 2021Q1 | 123.21 | 93 | -31.52 | -21 | -16.92 | 149 |